Login Register Cart 0
Generic placeholder image

Current HIV Research

Editor-in-Chief

ISSN (Print): 1570-162X
ISSN (Online): 1873-4251

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Assessment of Knowledge and Concern of People Living with HIV Regarding Human Mpox and Vaccination

Author(s): Deniz Borcak*, Yusuf Emre Özdemir, Zuhal Yesilbag, Esra Ensaroğlu, Samiha Akkaya and Kadriye Kart Yaşar

Volume 22, Issue 2, 2024

Published on: 02 May, 2024

Page: [120 - 127] Pages: 8

DOI: 10.2174/011570162X293673240427062123

Price: $65

Abstract

Introduction: Mpox virus is an orthopoxvirus that causes the zoonotic infectious disease known as mpox. The disease can also spread from humans to humans. It can be transmitted through contact with bodily fluids, lesions on the skin, or internal mucosal surfaces.

Method: The number of mpox cases increased during the COVID-19 pandemic. Early diagnosis and prompt management of mpox are critical in people living with HIV (PLHIV). In this study, a cross-sectional survey was conducted among PLHIV followed at the outpatient clinic between 20 April–20 August 2023. A questionnaire was used to assess the knowledge and anxiety levels of patients as well as their opinions about vaccination against mpox. The severity of symptoms in the past two weeks was assessed using the Generalised Anxiety Disorder 7-item scale. A total of 203 PLHIV were interviewed for this survey study.

Result: The mean age was 39.37±11.93. The majority of them were male (86.7%), and 41.4% were men who have sex with men (MSM). Only 21 of the surveyed participants (10.4%) had a “good knowledge” score about mpox. The mean knowledge score on human Mpox was 2.05 (min:0-max:8), and 107 (52.7%) had a score of 0.

Conclusion: The future study should focus on continuous education, promoting awareness through programs and establishing measures to successfully overcome identified variables that contribute to mpox pandemic understanding and attitudes. Applying the lessons learned from the COVID-19 pandemic will help the management of mpox virus.

« Previous Next »
Graphical Abstract

[1]
Saavedra OB, Figueroa LDA, Madariaga MES, et al. Antiviral treatment against monkeypox: A scoping review. Trop Med Infect Dis 2022; 7(11): 369.
[http://dx.doi.org/10.3390/tropicalmed7110369] [PMID: 36355910]
[2]
Sohn EJ. Functional analysis of monkeypox and interrelationship between monkeypox and COVID-19 by bioinformatic analysis. Genet Res 2023; 2023: 1-11.
[http://dx.doi.org/10.1155/2023/8511036] [PMID: 37006463]
[3]
Alakunle E, Moens U, Nchinda G, Okeke MI. Monkeypox virus in Nigeria: Infection biology, epidemiology, and evolution. Viruses 2020; 12(11): 1257.
[http://dx.doi.org/10.3390/v12111257] [PMID: 33167496]
[4]
Kumar N, Acharya A, Gendelman HE, Byrareddy SN. The 2022 outbreak and the pathobiology of the monkeypox virus. J Autoimmun 2022; 131: 102855.
[http://dx.doi.org/10.1016/j.jaut.2022.102855] [PMID: 35760647]
[5]
Pinto P, Costa MA, Gonçalves MFM, Rodrigues AG, Lisboa C. Mpox person-to-person transmission—where have we got so far? a systematic review. Viruses 2023; 15(5): 1074.
[http://dx.doi.org/10.3390/v15051074] [PMID: 37243160]
[6]
Nolasco S, Vitale F, Geremia A, et al. First case of monkeypox virus, SARS-CoV-2 and HIV co-infection. J Infect 2023; 86(1): e21-3.
[http://dx.doi.org/10.1016/j.jinf.2022.08.014] [PMID: 35995308]
[7]
Derin O, Öztürk EN, Demirbaş ND, Sevgi DY, Dökmetaş İ. A patient presented with genital eruptions: The second case of monkeypox from türkiye. Mikrobiyol Bul 2023; 57(1): 134-40.
[http://dx.doi.org/10.5578/mb.20239911] [PMID: 36636852]
[8]
Mpox outbreak global map. 2022. Available from: https://www.cdc.gov/poxvirus/mpox/response/2022/world-map.html
[9]
Saldana CS, Kelley CF, Aldred BM, Cantos VD. Mpox and HIV: A narrative review. Curr HIV/AIDS Rep 2023; 20(4): 261-9.
[http://dx.doi.org/10.1007/s11904-023-00661-1] [PMID: 37178205]
[10]
Elsayed S, Bondy L, Hanage WP. Monkeypox virus infections in humans. Clin Microbiol Rev 2022; 35(4): e00092-22.
[http://dx.doi.org/10.1128/cmr.00092-22] [PMID: 36374082]
[11]
Reynolds M, McCollum A, Nguete B, Lushima SR, Petersen B. Improving the care and treatment of monkeypox patients in low-resource settings: Applying evidence from contemporary biomedical and smallpox biodefense research. Viruses 2017; 9(12): 380.
[http://dx.doi.org/10.3390/v9120380] [PMID: 29231870]
[12]
Eustaquio PC, Salmon-Trejo LAT, McGuire LC, Ellington SR. Epidemiologic and clinical features of mpox in adults aged >50 years - United States, May 2022-May 2023. MMWR Morb Mortal Wkly Rep 2022; 72(33): 893-6.
[13]
Matusali G, Petruccioli E, Cimini E, et al. Evaluation of cross-immunity to the mpox virus due to historic smallpox vaccination. Vaccines 2023; 11(10): 1541.
[14]
Turpin RE, Mandell CJ, Camp AD, et al. Monkeypox-related stigma and vaccine challenges as a barrier to HIV pre-exposure prophylaxis among black sexual minority men. Int J Environ Res Public Health 2023; 20(14): 6324.
[http://dx.doi.org/10.3390/ijerph20146324] [PMID: 37510557]
[15]
Mitjà O, Alemany A, Marks M, et al. Mpox in people with advanced HIV infection: A global case series. Lancet 2023; 401(10380): 939-49.
[http://dx.doi.org/10.1016/S0140-6736(23)00273-8] [PMID: 36828001]
[16]
Curran KG, Eberly K. HIV and sexually transmitted infections among persons with monkeypox - eight U.S. Jurisdictions, May 17-July 22, 2022. MMWR Morb Mortal Wkly Rep 2022; 71(36): 1141-7.
[17]
Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006; 166(10): 1092-7.
[http://dx.doi.org/10.1001/archinte.166.10.1092] [PMID: 16717171]
[18]
Gallè F, Bianco L, Da Molin G, et al. “Monkeypox: What do you know about that?” italian adults’ awareness of a new epidemic. Pathogens 2022; 11(11): 1285.
[http://dx.doi.org/10.3390/pathogens11111285] [PMID: 36365036]
[19]
Peptan C, Băleanu VD, Mărcău FC. Study on the vaccination of the population of romania against monkeypox in terms of medical security. Vaccines 2022; 10(11): 1834.
[http://dx.doi.org/10.3390/vaccines10111834] [PMID: 36366343]
[20]
Aljamaan F, Alenezi S, Alhasan K, et al. Healthcare workers’ worries and monkeypox vaccine advocacy during the first month of the WHO monkeypox alert: Cross-sectional survey in Saudi Arabia. Vaccines 2022; 10(9): 1408.
[http://dx.doi.org/10.3390/vaccines10091408] [PMID: 36146486]
[21]
Hong J, Pan B, Jiang HJ, et al. The willingness of Chinese healthcare workers to receive monkeypox vaccine and its independent predictors: A cross-sectional survey. J Med Virol 2023; 95(1): e28294.
[http://dx.doi.org/10.1002/jmv.28294] [PMID: 36367155]
[22]
Mahameed H, Al-Mahzoum K, AlRaie LA, et al. Previous vaccination history and psychological factors as significant predictors of willingness to receive mpox vaccination and a favorable attitude towards compulsory vaccination. Vaccines 2023; 11(5): 897.
[http://dx.doi.org/10.3390/vaccines11050897] [PMID: 37243001]
[23]
Majid U, Ahmad M, Zain S, Akande A, Ikhlaq F. COVID-19 vaccine hesitancy and acceptance: a comprehensive scoping review of global literature. Health Promot Int 2022; 37(3): daac078.
[http://dx.doi.org/10.1093/heapro/daac078] [PMID: 35788306]
[24]
Ştefănuţ AM, Vintilă M, Tomiţă M, Treglia E, Lungu MA, Tomassoni R. The influence of health beliefs, of resources, of vaccination history, and of health anxiety on intention to accept covid-19 vaccination. Front Psychol 2021; 12: 729803.
[http://dx.doi.org/10.3389/fpsyg.2021.729803] [PMID: 34594282]
[25]
Swed S, Bohsas H, Alibrahim H, et al. Monkeypox post-COVID-19: Knowledge, worrying, and vaccine adoption in the arabic general population. Vaccines 2023; 11(4): 759.
[http://dx.doi.org/10.3390/vaccines11040759] [PMID: 37112671]
[26]
Sallam M, Al-Mahzoum K, Dardas LA, et al. Knowledge of human monkeypox and its relation to conspiracy beliefs among students in jordanian health schools: Filling the knowledge gap on emerging zoonotic viruses. Medicina 2022; 58(7): 924.
[http://dx.doi.org/10.3390/medicina58070924] [PMID: 35888642]
[27]
Camara A, Sow MS, Touré A, et al. Anxiety and depression among HIV patients of the infectious disease department of Conakry University Hospital in 2018. Epidemiol Infect 2020; 148: e8.
[28]
Beer L, Tie Y, Padilla M, Shouse RL. Generalized anxiety disorder symptoms among persons with diagnosed HIV in the United States. AIDS 2019; 33(11): 1781-7.
[http://dx.doi.org/10.1097/QAD.0000000000002286] [PMID: 31211718]
[29]
Nyongesa MK, Mwangi P, Koot HM, Cuijpers P, Newton CRJC, Abubakar A. The reliability, validity and factorial structure of the Swahili version of the 7-item generalized anxiety disorder scale (GAD-7) among adults living with HIV from Kilifi, Kenya. Ann Gen Psychiatry 2020; 19(1): 62.
[http://dx.doi.org/10.1186/s12991-020-00312-4] [PMID: 33133222]
[30]
Ahmed SK, Mohamed MG, Dabou EA, et al. Monkeypox (mpox) in immunosuppressed patients. F1000 Res 2023; 12: 127.
[http://dx.doi.org/10.12688/f1000research.130272.2] [PMID: 37089133]
[31]
Knight J, Tan DHS, Mishra S. Maximizing the impact of limited vaccine supply under different early epidemic conditions: a 2-city modelling analysis of monkeypox virus transmission among men who have sex with men. CMAJ 2022; 194(46): E1560-7.
[http://dx.doi.org/10.1503/cmaj.221232] [PMID: 36442881]
[32]
O’Shea J, Filardo TD, Morris SB, Weiser J, Petersen B, Brooks JT. Interim guidance for prevention and treatment of monkeypox in persons with HIV infection — United States, August 2022. MMWR Morb Mortal Wkly Rep 2022; 71(32): 1023-8.
[http://dx.doi.org/10.15585/mmwr.mm7132e4] [PMID: 35951495]
[33]
Shin MB, Sloan KE, Martinez B, et al. Examining multilevel influences on parental HPV vaccine hesitancy among multiethnic communities in Los Angeles: A qualitative analysis. BMC Public Health 2023; 23(1): 545.
[http://dx.doi.org/10.1186/s12889-023-15318-2] [PMID: 36949438]
[34]
Rachiotis G, Mouchtouri VA, Kremastinou J, Gourgoulianis K, Hadjichristodoulou C. Low acceptance of vaccination against the 2009 pandemic influenza A(H1N1) among healthcare workers in Greece. Euro Surveill 2010; 15(6): 19486.
[http://dx.doi.org/10.2807/ese.15.06.19486-en] [PMID: 20158980]
[35]
Temsah MH, Aljamaan F, Alenezi S, et al. Monkeypox caused less worry than COVID-19 among the general population during the first month of the WHO Monkeypox alert: Experience from Saudi Arabia. Travel Med Infect Dis 2022; 49: 102426.
[http://dx.doi.org/10.1016/j.tmaid.2022.102426] [PMID: 35963555]
[36]
Sahin TK, Erul E, Aksun MS, Sonmezer MC, Unal S, Akova M. Knowledge and attitudes of turkish physicians towards human mpox disease and related vaccination: A cross-sectional study. Vaccines 2022; 11(1): 19.
[37]
Svartstein ASW, Knudsen AD, Heidari SL, et al. Mpox incidence and vaccine uptake in men who have sex with men and are living with HIV in Denmark. Vaccines 2023; 11(7): 1167.
[http://dx.doi.org/10.3390/vaccines11071167] [PMID: 37514983]
[38]
Ghaffar RA, Shahnoor S, Farooq M. Increased prevalence of HIV among Monkeypox patients – An alarming update. New Microbes New Infect 2022; 49-50: 101039.
[http://dx.doi.org/10.1016/j.nmni.2022.101039] [PMID: 36284774]
[39]
Antinori S, Casalini G, Giacomelli A, Morales RAJ. Update on Mpox: A brief narrative review. Infez Med 2023; 31(3): 269-76.
[PMID: 37701385]
[40]
Hamdana AH, Mohsin H, Tharwani HZ, et al. Monkeypox virus and other emerging outbreaks: An overview and future perspective. Inquiry 2023; 60(69580231175437)
[http://dx.doi.org/10.1177/00469580231175437] [PMID: 37190997]
[41]
Al-Sanafi M, Sallam M. Psychological determinants of COVID-19 vaccine acceptance among healthcare workers in Kuwait: A cross-sectional study using the 5c and vaccine conspiracy beliefs scales. Vaccines 2021; 9(7): 701.
[http://dx.doi.org/10.3390/vaccines9070701] [PMID: 34202298]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy